{"id":"W1987945639","doi":"10.1016/j.ejca.2011.10.035","title":"Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo","year":2011,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Dr. H. Bliss Murphy Cancer Centre; Ottawa Hospital; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Erlotinib; Internal medicine; Comorbidity; Gemcitabine; Hazard ratio; Erlotinib Hydrochloride; Proportional hazards model; Pancreatic cancer; Placebo; Oncology; Cancer; Epidermal growth factor receptor; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009754902,0.0007284505,0.001550388,0.0002394041,0.0003048085,0.000730478,0.0005399012,0.0007782736,0.001763609],"category_scores_gemma":[0.0009972465,0.0003121149,0.001591722,0.0004996579,0.000383979,0.0005565,0.0003594569,0.001712682,0.0002506629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005716384,"about_ca_system_score_gemma":0.0006682061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001796476,"about_ca_topic_score_gemma":0.003762903,"domain_scores_codex":[0.9996921,0.0001555353,0.00002937141,0.00004063957,0.00003037952,0.00005201351],"domain_scores_gemma":[0.9992334,0.0001538495,0.0002471869,0.00005929697,0.00002804465,0.0002783558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9048663,0.003917947,0.05230489,0.0003573046,0.0041399,0.00009726738,0.00005987357,0.001268656,0.003940639,0.00007846183,0.001691219,0.02727757],"study_design_scores_gemma":[0.3894718,0.1339236,0.4621955,0.0001132778,0.007286134,0.0004206622,0.0001520576,0.002284105,0.001302791,0.0003722098,0.002384462,0.00009332278],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955389,0.003121701,0.00004647494,0.0002124693,0.00005421504,0.00006793628,0.000386347,0.0000111228,0.0005607909],"genre_scores_gemma":[0.9967402,0.001288073,0.0001339633,0.0002637681,0.0001236865,0.0000855724,0.0009455697,0.00000545143,0.0004139049],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001796476,"threshold_uncertainty_score":0.005899847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0716409338928136,"score_gpt":0.3556097789209846,"score_spread":0.283968845028171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}